Y. Mao

发表

Consensus on the diagnosis and treatment of cholestatic liver diseases (2015, China)

Yue Zhang, Hong Tang, Lungen Lu, 2016, Journal of digestive diseases.

Pharmacotherapy of nonalcoholic steatohepatitis: Reflections on the existing evidence

Jie-ting Tang, Y. Mao, 2017, Journal of digestive diseases.

HEPATOLOGY: Simpler score of routine laboratory tests predicts liver fibrosis in patients with chronic hepatitis B

Hai-Lin Liu, Lungen Lu, Yun-peng Zhao, 2010 .

Prediction of significant fibrosis in HBeAg‐positive patients with chronic hepatitis B by a noninvasive model

Lungen Lu, Chunfang Gao, Xia-qiu Zhou, 2005, Hepatology.

Relationship between clinical and pathologic findings in patients with chronic liver diseases.

Jun Ye, Jing-Yuan Fang, Lungen Lu, 2003, World journal of gastroenterology.

Gene-metabolite network analysis in different nonalcoholic fatty liver disease phenotypes

Jingyi Zhang, M. Zeng, Yanan Ming, 2017, Experimental & Molecular Medicine.

Capsule oxymatrine in treatment of hepatic fibrosis due to chronic viral hepatitis: a randomized, double blind, placebo-controlled, multicenter clinical study.

Jun Ye, Lungen Lu, Xia-qiu Zhou, 2004, World journal of gastroenterology.

Research Methods and Techniques for Acute Exacerbation of Chronic Hepatitis B

Tao Chen, Zhi Chen, D. Xi, 2019, Acute Exacerbation of Chronic Hepatitis B.

[Validation of transient elastography (Fibroscan) in assessment of hepatic fibrosis in autoimmune hepatitis].

Xiong Ma, Lei Shen, Qi-xia Wang, 2011, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

Oxymatrine therapy for chronic hepatitis B: a randomized double-blind and placebo-controlled multi-center trial.

Jun Ye, Lungen Lu, Xia-qiu Zhou, 2003, World journal of gastroenterology.

Lungen Lu, Jian-Gao Fan, Youqing Xu, 2021, Health and Quality of Life Outcomes.

Effect of oxymatrine on expressions of type I, III, IV collagen in CCl4 induced liver fibrosis in rats

Lungen Lu, D. Qiu, M. Zeng, 2003 .

CSH guidelines for the diagnosis and treatment of drug-induced liver injury

W. Cong, Lungen Lu, Chang-qing Yang, 2017, Hepatology International.

Inhibitory effect of oxymatrine on serum hepatitis B virus DNA in HBV transgenic mice.

Lungen Lu, M. Zeng, Y. Mao, 2004, World journal of gastroenterology.

Inhibitory effect of oxymatrine on ex- pression of hepatitis B virus in HBV transgenic mice

Lungen Lu, D. Qiu, M. Zeng, 2004 .

Heteroaryldihydropyrimidine (HAP) and Sulfamoylbenzamide (SBA) Inhibit Hepatitis B Virus Replication by Different Molecular Mechanisms

F. García-Alcalde, J. Young, Zhiheng Xu, 2017, Scientific Reports.

Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases *

Bing Yuan Wang, Lungen Lu, You-Ming Li, 2008, Journal of digestive diseases.

Grading and staging of hepatic fibrosis, and its relationship with noninvasive diagnostic parameters.

Xiong Cai, Jun Ye, Lungen Lu, 2003, World journal of gastroenterology.

Guidelines for the diagnosis and treatment of alcoholic liver disease *

Lungen Lu, You-Ming Li, M. Zeng, 2008, Journal of digestive diseases.

[Magnesium isoglycyrrhizinate in the treatment of chronic liver diseases: a randomized, double-blind, multi-doses, active drug controlled, multi-center study].

Ying Sun, Lungen Lu, Xiong Cai, 2009, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

[Therapeutic effect of diammonium glycyrrhizinate lipid ligand on carbon-tetrarchloride induced fatty livers in rats].

Lungen Lu, M. Zeng, Y. Mao, 2005, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

Corticosteroid plus glycyrrhizin therapy for chronic drug‐ or herb‐induced liver injury achieves biochemical and histological improvements: a randomised open‐label trial

Ying Sun, Ming Niu, G. Aithal, 2022, Alimentary pharmacology & therapeutics.

Stages of psychological change among patients with non-alcoholic fatty liver disease in China: a national cross-sectional study

Lungen Lu, Lai Wei, B. Zhong, 2023, BMJ Open.

Liquid chromatography mass spectrometry-based profiling of phosphatidylcholine and phosphatidylethanolamine in the plasma and liver of acetaminophen-induced liver injured mice

Xiaobo Li, Jingyi Zhang, Chunmin Li, 2017, Lipids in Health and Disease.

Silymarin for Treating Toxic Liver Disease: International Consensus Recommendations

R. Andrade, M. Lucena, Qing‐chun Fu, 2022, Gastro Hep Advances.

Reliability and validity of the Chinese version of chronic liver disease questionnaire-nonalcoholic fatty liver disease in patients with nonalcoholic fatty liver disease: a multicenter cross-sectional survey in China

Lungen Lu, Lai Wei, B. Zhong, 2023, Quality of Life Research.

Tolvaptan in Chinese cirrhotic patients with ascites: A randomized, placebo‐controlled phase 2 trial

Zheng Wang, H. Ding, Jun Cheng, 2018, Journal of digestive diseases.